Chronic Lymphocytic Leukemia (CLL): What Are My Treatment Options?
Topics Covered
We invite you to learn more about:
- Treatment options for CLL
- Side-effects management
- Ways to effectively communicate with your healthcare team about quality-of-life issues
Speaker
Jennifer Woyach, MD
Associate Professor
Section Head, CLL and Hairy Cell Leukemia
Associate Division Director for Clinical Research
Division of Hematology
Department of Internal Medicine
The Ohio State University
Columbus, OH
Audio Replay
Program Materials
Program Support
Support for this program is provided by Genentech & Biogen; Pharmacylics, An AbbVie Company & Janssen Biotech; and The Leukemia & Lymphoma Society.
Advances in Treatment for Chronic Lymphocytic Leukemia (CLL)
Topics Covered
We invite you to learn more about:
- Current and emerging therapies for CLL
- Managing side effects to promote a better quality of life
- The impact of COVID-19 on CLL treatment decisions
Speaker
Tanya Siddiqi, MD
Associate Clinical Professor
Director, Chronic Lymphocytic Leukemia Program
Department of Hematology & HCT
City of Hope Medical Center
Duarte, CA
Audio Replay
Program Materials
Program Support
Support for this program is provided by Genentech & Biogen, and Pharmacylics, An AbbVie Company & Janssen Biotech.
The Future of CLL Treatment: What’s Next?
Topics Covered
We invite you to learn more about:
- Watch and wait (active monitoring) for chronic lymphocytic leukemia (CLL)
- New and emerging therapies for CLL
- Side-effect management
- Late effects of treatment
- Shared decision-making with your treatment team
Program Materials
Speaker
Adam S Kittai, MD
Hematologist/Oncologist
Associate Professor
Assistant Director, Lymphoma Clinical Research
Leader, CLL Clinical Research
Icahn School of Medicine at Mount Sinai
New York, NY
Program Support
Support for this program provided by AbbVie Inc., BeiGene USA, Inc., Genentech, Inc. & Biogen, and Lilly.
Fact or Fiction? CLL Treatment and Side Effects
Topics Covered
When searching for chronic lymphocytic leukemia (CLL) information online, how do you know what’s credible? In this webinar, Dr. Javier Pinilla-Ibarz, will review current CLL treatments, emerging research and common side effects to help you decipher fact from fiction.
Speaker
Javier Pinilla-Ibarz, MD, PhD
Lymphoma Section Head and Director of Immunotherapy
Malignant Hematology Department
H. Lee Moffitt Cancer Center & Research Institute
Program Support
This webinar is brought to you by the Patient Empowerment Network, in partnership with The Leukemia & Lymphoma Society. We thank Genentech and Pharmacyclics for their support.
CLL: Navigating Treatment with BTK Inhibitors
Presentation
CancerCoachLive invites you to join 2 expert hematology/oncology clinicians and a CLL patient for a 1-hour live, online, interactive discussion led by led by Dr. Matthew Davids, Associate Professor of Medicine, Harvard Medical School, Associate Director, Center for Chronic Lymphocytic Leukemia, Dana-Farber Cancer Institute.
This program will cover the challenges associated with BTK-inhibitor use in the treatment of CLL. Panelists will discuss the latest findings on long-term efficacy, side-effect management, and adopting healthy lifestyles to improve outcomes.
Watch this program and you will learn about:
- Available and recommended treatment options for CLL at all stages of disease
- Basic details about available BTK inhibitors from a patient’s perspective
- How patients and their caregivers can help align perspectives with healthcare providers
When you register, you may submit questions to the expert panel.
Living With Chronic Lymphocytic Leukemia (CLL)
We invite you to learn more about:
- Treatment goals for a chronic disease
- New and emerging therapies for CLL
- Side-effect management
- The importance of open communication with your healthcare team
Stephen E. Spurgeon, MD
Associate Professor of Medicine
School of Medicine
Oregon Health & Science University
Hematology/Oncology
Portland, OR
Program Support
Support for this program is provided by Genentech, Inc. & Biogen, Eli Lilly and Company, and Pharmacylics, An AbbVie Company & Janssen Biotech.
Spotlight on Chronic Lymphocytic Leukemia (CLL)
We invite you to learn more about:
- Emerging therapies and clinical trials for CLL
- Managing side effects
- Strategies to improve your quality of life
Nicole Lamanna, MD
Associate Attending, Leukemia Service
Director, Chronic Lymphocytic Leukemia Program
Hematologic Malignancies Section
Herbert Irving Comprehensive Cancer Center
NewYork-Presbyterian/Columbia University Medical Center
New York, NY
Program Support
Support for this program provided by: AbbVie Inc. - BeiGene; Eli Lilly and Company - Pharmacyclics - An AbbVie Company & Janssen Biotech - and the Thomas D. Oxley Fund for CLL Patient Education & Support.